|

Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

RECRUITINGSponsored by Lilli Health
Actively Recruiting
SponsorLilli Health
Started2024-02-01
Est. completion2026-10
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age: Participants aged 18+ years.
* Sex: Both males and females.
* Race/Ethnicity: Participants from diverse racial and ethnic backgrounds
* BMI: Participants with a range of body mass index (BMI) values
* PCOS Diagnosis: Participants with and without a confirmed diagnosis PCOS based on established diagnostic criteria.

Exclusion Criteria:

* Age: Participants below 18 years
* Sex: None. Both males and females are included.
* Race/Ethnicity: None. Participants from all racial and ethnic backgrounds are included.
* Endocrine Disorders: Participants with other endocrine disorders affecting insulin levels, such an insulin secreting tumor.

Conditions7

CancerDiabetesHyperinsulinismInsulin ResistanceMetabolic SyndromeObesityPolycystic Ovary Syndrome

Locations1 site

Lilli Health
Houston, Texas, 77554
Ali M Chappell, PhD, MS, RD8064417275achappell@lillihealth.com

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.